CYCLOPENTANECARBOXYLIC ACID, 2-OXO-, 1-METHYLETHYL ESTER, 95%, 100mg

1-(2-methyl-4-nitrophenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 1g

1-[3,5-dimethyl-4-(4-nitrophenoxy)phenyl]ethanone, 95.0%, 1g

N*1*-(3-Bromo-benzyl)-N*1*-ethyl-ethane-1,2-diamine, 97%, 250mg

Methyl 2-(2-bromo-3-chlorophenyl)acetate, 95%, 5g

Methyl 4-[4-(chloromethyl)-1,3-thiazol-2-yl]benzoate, 95%, 5g

tert-butyl 3-{[(2-chlorophenyl)methyl]amino}propanoate, 95.0%, 10g

cis-4-(Hydroxymethyl)cyclohexanecarboxylic Acid>98.0%(GC)5g

GC capillary column ROTI®Cap-1, 25 m, 0.32 mm, 1.00 µm, 1 Piece(s)

8-chloro-2-hydroxyquinoline-4-carboxylic acid, 1g

TERT-BUTYL 5-TERT-BUTYLISOXAZOL-3-YLCARBAMATE, 95.0%, 250mg

3-(2,6-Dimethylphenyl)-2-methyl-1-propene, 97.0%, 1g

TRANS-3-AMINO-2,2-DIMETHYLCYCLOBUTANOL HCL, 95.0%, 250mg